STAGE IIIC PROSTATE CANCER AJCC V8
Clinical trials for STAGE IIIC PROSTATE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIC PROSTATE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIC PROSTATE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation schedule may cut treatment time for prostate cancer patients
Disease control CompletedThis phase II trial tested a shorter course of higher-dose radiation (hypofractionation) in 53 men with high-risk prostate cancer who had already had their prostate removed. The goal was to see if this approach could control cancer while reducing side effects. Participants also r…
Matched conditions: STAGE IIIC PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug combo aims to stop high-risk prostate cancer in its tracks
Disease control CompletedThis study tested whether adding the drug niraparib to standard radiation and hormone therapy can help prevent high-risk prostate cancer from coming back. Niraparib blocks a protein that cancer cells use to repair their DNA, which may kill them. The trial enrolled 22 men with agg…
Matched conditions: STAGE IIIC PROSTATE CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Experimental drug combo targets Hard-to-Treat cancers
Disease control CompletedThis early-phase trial tested a new drug called AZD8186 combined with the chemotherapy docetaxel in 23 patients with advanced solid tumors that have PTEN or PIK3CB gene mutations. The main goal was to find the safest dose and understand side effects. The study is complete, but re…
Matched conditions: STAGE IIIC PROSTATE CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Cancer moonshot study banks tissue to unlock genetic secrets
Knowledge-focused CompletedThis completed study collected blood and tumor tissue from 64 patients with advanced cancers (like melanoma, breast, lung, and kidney cancer) to study genetic changes and treatment resistance. The samples are stored for future research, including genomic analysis. No new treatmen…
Matched conditions: STAGE IIIC PROSTATE CANCER AJCC V8
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Smart devices track cancer recovery at home
Knowledge-focused CompletedThis study tested whether using at-home monitoring devices (like a wristband pedometer, scale, and blood pressure cuff) can help improve care for cancer patients after they leave the hospital following surgery. 22 patients with various cancers participated. The goal was to see if…
Matched conditions: STAGE IIIC PROSTATE CANCER AJCC V8
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
New web tool aims to simplify genetic testing decisions for prostate cancer patients
Knowledge-focused CompletedThis study tested a mobile-friendly web tool that educates men with prostate cancer about genetic testing. Researchers compared traditional genetic counseling with the online tool to see if it helps patients decide whether to get tested. The study involved 346 men with advanced o…
Matched conditions: STAGE IIIC PROSTATE CANCER AJCC V8
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC